← Leaderboards
Chaim Putterman
Yeshiva University
$10,696,502
Attributed
$14,929,209
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,929,209 · 7
By mechanism
R01$7,962,768 · 3
UH2$6,349,061 · 1
R56$365,200 · 1
K08$252,180 · 1
P01$0 · 1
Top collaborators
- Jill P Buyon11 shared
- Thomas Tuschl11 shared
Most similar at Yeshiva University
Same institution · by research overlap
- Christine Mary Grimaldi$615,847
Others in their field
Top investigators on “Systemic Lupus Erythematosus”
- Ignacio E. Sanz · University Of Rochester$57,737,718
- George C Tsokos · Beth Israel Deaconess Medical Center$37,219,358
- David Wofsy · University Of California, San Francisco$36,472,228
- Betty Diamond · Feinstein Institute For Medical Research$32,406,714
- John Barker Harley · Cincinnati Va Medical Center Research$30,355,689
- Patrick M Gaffney · University Of Minnesota Twin Cities$27,964,103
Research focus
Systemic Lupus ErythematosusLupusCellsAntibodiesNephritisPathway InteractionsCytokineKidney CellGene ExpressionLupus NephritisKidney DiseasesKidneyIncidenceSignal TransductionDepositionBaseEndothelial CellsDiagnosticIn VivoInflammatoryOrganIn VitroPathogenesisCohort
Grant awards (38)
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$481,619
UH2 · FY2020 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$1,117,810
UH2 · FY2019 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$105,524
UH2 · FY2019 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$944,516
UH2 · FY2018 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$371,492
R01 · FY2018 · AR · contact PI
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$111,125
R01 · FY2018 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$686,349
UH2 · FY2017 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$482,617
R01 · FY2017 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$366,395
UH2 · FY2017 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$578,905
UH2 · FY2016 · AR
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$498,441
UH2 · FY2016 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$482,617
R01 · FY2016 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$169,500
UH2 · FY2016 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$99,999
R01 · FY2016 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2015 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$404,394
R01 · FY2015 · AR · contact PI
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$78,223
R01 · FY2015 · AR · contact PI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium$700,001
UH2 · FY2014 · AR
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric$404,394
R01 · FY2014 · AR · contact PI
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis$361,050
R01 · FY2014 · DK · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$478,102
R01 · FY2013 · AR · contact PI
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis$348,414
R01 · FY2013 · DK · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$503,265
R01 · FY2012 · AR · contact PI
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis$361,050
R01 · FY2012 · DK · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$503,265
R01 · FY2011 · AR · contact PI
TNF-like weak inducer of apoptosis (TWEAK) signaling: a novel therapeutic target$415,000
R01 · FY2011 · DK · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$521,784
R01 · FY2010 · AR · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$373,500
R01 · FY2009 · AR · contact PI
The Renal Pathogenicity of anti-DNA Antibodies$149,566
R01 · FY2009 · AR · contact PI
The Renal Pathogenicity of Anti-DNA Antibodies$365,200
R56 · FY2008 · AR · contact PI
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies$282,121
R01 · FY2006 · AR · contact PI
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies$288,910
R01 · FY2005 · AR
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies$313,960
R01 · FY2004 · AR
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies$313,960
R01 · FY2003 · AR
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies$313,960
R01 · FY2002 · AR
Alpha-Actinin /Renal Pathogenicity of Anti-DNA Anibodies$0
P01 · FY2002 · AI
RENAL PATHOGENICITY OF ANTIDNA ANTIBODIES$126,090
K08 · FY2001 · AR
RENAL PATHOGENICITY OF ANTIDNA ANTIBODIES$126,090
K08 · FY2000 · AR